Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Androidâ„¢ device!
Free
Faster access than browser!
 

Deslorelin and Index of oncology articles

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Deslorelin and Index of oncology articles

Deslorelin vs. Index of oncology articles

Deslorelin, sold under the brand names Ovuplant, SucroMate, and Suprelorin among others, is an injectable gonadotropin releasing hormone superagonist (GnRH agonist) which is used in veterinary medicine for various indications. This is a list of terms related to oncology.

Similarities between Deslorelin and Index of oncology articles

Deslorelin and Index of oncology articles have 9 things in common (in Unionpedia): Bioavailability, Clinical trial, Endometriosis, Gonadotropin-releasing hormone, Gonadotropin-releasing hormone agonist, Human chorionic gonadotropin, National Cancer Institute, National Institutes of Health, Prostate cancer.

Bioavailability

In pharmacology, bioavailability (BA or F) is a subcategory of absorption and is the fraction of an administered dose of unchanged drug that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs.

Bioavailability and Deslorelin · Bioavailability and Index of oncology articles · See more »

Clinical trial

Clinical trials are experiments or observations done in clinical research.

Clinical trial and Deslorelin · Clinical trial and Index of oncology articles · See more »

Endometriosis

Endometriosis is a condition in which the endometrium, the layer of tissue that normally covers the inside of the uterus, grows outside of it.

Deslorelin and Endometriosis · Endometriosis and Index of oncology articles · See more »

Gonadotropin-releasing hormone

Gonadotropin-releasing hormone (GnRH) also known as gonadoliberin, and by various other names in its endogenous form and as gonadorelin in its pharmaceutical form, is a releasing hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary.

Deslorelin and Gonadotropin-releasing hormone · Gonadotropin-releasing hormone and Index of oncology articles · See more »

Gonadotropin-releasing hormone agonist

A gonadotropin-releasing hormone agonist (GnRH agonist) is a type of medication which affects gonadotropins and sex hormones.

Deslorelin and Gonadotropin-releasing hormone agonist · Gonadotropin-releasing hormone agonist and Index of oncology articles · See more »

Human chorionic gonadotropin

Human chorionic gonadotropin (hCG) is a hormone produced by the placenta after implantation.

Deslorelin and Human chorionic gonadotropin · Human chorionic gonadotropin and Index of oncology articles · See more »

National Cancer Institute

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of eleven agencies that are part of the U.S. Department of Health and Human Services.

Deslorelin and National Cancer Institute · Index of oncology articles and National Cancer Institute · See more »

National Institutes of Health

The National Institutes of Health (NIH) is the primary agency of the United States government responsible for biomedical and public health research, founded in the late 1870s.

Deslorelin and National Institutes of Health · Index of oncology articles and National Institutes of Health · See more »

Prostate cancer

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.

Deslorelin and Prostate cancer · Index of oncology articles and Prostate cancer · See more »

The list above answers the following questions

Deslorelin and Index of oncology articles Comparison

Deslorelin has 34 relations, while Index of oncology articles has 1711. As they have in common 9, the Jaccard index is 0.52% = 9 / (34 + 1711).

References

This article shows the relationship between Deslorelin and Index of oncology articles. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »